Cabergoline EP Impurity A CAS No.: 81409-74-7

Chemical Structure : Cabergoline EP Impurity A

CAS No.: 81409-74-7

 

Cabergoline EP Impurity A

Catalog No.: URK-V2459 Only Used For Lab.

Cabergoline EP Impurity A is a pharmaceutical compound that is used in the treatment of hyperprolactinemia. Its therapeutic effectiveness is attributed to its ability to selectively bind to D2 dopamine receptors and inhibit prolactin secretion.

Biological Activity

Cabergoline EP Impurity A is a potent D2 dopamine receptor agonist that acts by binding to dopamine receptors and effectively inhibiting the secretion of prolactin.
Hyperprolactinemia is a condition that is caused by elevated levels of prolactin in the blood and is associated with several clinical manifestations that include infertility, menstrual irregularities, and galactorrhea. The use of Cabergoline EP Impurity A is recommended for the management of hyperprolactinemia, and its therapeutic effectiveness has been proven in several clinical trials.
Cabergoline EP Impurity A works by selectively binding to dopamine receptors and effectively inhibiting the secretion of prolactin. The compound has a high affinity for D2 dopamine receptors, and its action is dose-dependent. The therapeutic effectiveness of Cabergoline EP Impurity A has been demonstrated in several clinical trials and is considered a first-line option for the treatment of hyperprolactinemia.

Physicochemical Properties

References

1. Webster J. A new treatment for hyperprolactinaemia: Cabergoline, a long-acting dopamine agonist. Clin Endocrinol (Oxf). 1994 Jan;40(1):1-7.

2. Colao A, Pivonello R, Di Sarno A, et al. The cabergoline test: a new tool for the diagnosis of hyperprolactinemia. J Clin Endocrinol Metab. 1998 Jul;83(7):2248-51.

3. Stalla GK, Weintraub BD. Diagnosis and treatment of hyperprolactinemia. JAMA. 1997 May 14;277(18):1466-70.

URK-V2459_COA

URK-V2459_SDS

URK-V2459_TDS

Hot Tags: Cabergoline EP Impurity A CAS No.: 81409-74-7, China Cabergoline EP Impurity A CAS No.: 81409-74-7, epigenetic library for epigenetic resilience, epigenetic library for epigenetic silencing, inhibitors for metabolic disorders, agonists for host defense, epigenetic library for epigenetic regulation of cell amplification, epigenetic library for epigenetic analysis of epigenetic editing